Where does Independa, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Independa, Inc. ranks #47,641 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Independa, Inc. hold?

Independa, Inc. holds 5 US utility patents granted between 2018 and 2020, spanning 1 technology areas.

What is Independa, Inc.'s Innovation Score?

Independa, Inc. has an Innovation Score of 13.6 out of 100 (2nd percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Independa, Inc.'s patent grant rate increasing or decreasing?

Independa, Inc.'s recent grant velocity is -75% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Independa, Inc.'s patents?

Independa, Inc.'s patents average 6.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Independa, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Independa, Inc.

Q: What technology areas does Independa, Inc. focus on?

Independa, Inc.'s top technology area is G16H (Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data) with 1 patents. Grants appear in 1 CPC subclasses total.

USPTO PatentsView assignee record - 5 granted patents across 1 technology areas, recorded in grant years 2018–2020. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G16H (Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Independa ranks #47,641 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 1 technology areas.

#47,641
of 49,997 US assignees by volume: 2nd percentile
by Innovation Score (13.6/100): 6.4
avg claims per patent: -75%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R47641 · US Corporation #47,641 · 5 grants

GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-LOW · CLAIMS-SPARSE · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 5 grants
BOTTOM-DECILE #47,641/49,997
PHOTO-FINISH Incanthera
CPC-NARROW G16H · 1 areas
INNOV-LOW 13.6/100
CLAIMS-SPARSE 6.4 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -75% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Incanthera Ltd (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Independa · this assignee

14
3D Lighting… · lowest

7

What this shows Independa's Innovation Score is 13.6/100 (2nd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Independa's grants concentrate

Independa, Inc. is a focused PatentsView assignee: 1 CPC subclasses with 20% of grants classified under G16H (Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data). Peak complete grant year is 2018 (4 grants) versus a trough of 1 in 2020. By volume, Independa sits between Incanthera Ltd and Industrial Lighting Products, LLC..

Incanthera

5
Inception Innovat…

5
Incipio Devices

5
Incline Therapeut…

5
India Globalizati…

5
Indie Health

5
Indratech

5
Industrial Lighti…

5
Independa ◀

5

What this shows Independa holds 5 patents at rank #47,774, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Independa

By rank, the assignees closest to #47,774 in granted patent volume.

Leaders in G16H (Healthcare Informatics)

Other assignees with the most granted patents in Independa's primary technology class.

Independa's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

14 2nd percentile higher than 2% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2018–2020

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table

Independa, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2018	4	80.0%
2020	1	20.0%

Which technologies does Independa, Inc. patent most?

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 1

Top 1 of 1 technology areas

Where it ranks

Overall rank by patents

#47,641

of 49,997 tracked assignees

Innovation Score

13.6 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Independa, Inc.'s patent record in context - here's where to go next.

Independa, Inc.'s lead technology class is G16H (Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data), 20% of its portfolio - see every assignee active in that class. Explore G16H
Ranked #47,641 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Independa, Inc. against Incanthera Ltd, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 13.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.